Milestone Pharmaceuticals IncNASDAQ:MIST
- LAST PRICE1.5500
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots1.4900/ 2
- Ask / Lots1.5700/ 2
- Open / Previous Close1.5500 / 1.5500
- Day Range
- 52 Week Range
- Volume89,330
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MIST |
|---|---|---|
| 09:32 ET | 1336 | 1.548 |
| 09:39 ET | 786 | 1.53 |
| 09:57 ET | 100 | 1.5486 |
| 09:59 ET | 500 | 1.5495 |
| 10:03 ET | 1778 | 1.545 |
| 10:06 ET | 1100 | 1.54 |
| 10:12 ET | 600 | 1.5499 |
| 10:14 ET | 351 | 1.5474 |
| 10:19 ET | 100 | 1.535 |
| 10:24 ET | 1224 | 1.53 |
| 10:30 ET | 350 | 1.5225 |
| 10:37 ET | 200 | 1.53 |
| 10:42 ET | 1349 | 1.52 |
| 10:44 ET | 263 | 1.53 |
| 10:51 ET | 250 | 1.5201 |
| 10:57 ET | 100 | 1.5232 |
| 11:04 ET | 1201 | 1.52 |
| 11:09 ET | 100 | 1.52 |
| 11:18 ET | 103 | 1.5298 |
| 11:22 ET | 435 | 1.52 |
| 11:26 ET | 1549 | 1.525 |
| 11:33 ET | 400 | 1.52 |
| 11:38 ET | 100 | 1.51 |
| 11:45 ET | 400 | 1.5299 |
| 11:56 ET | 400 | 1.53 |
| 12:03 ET | 221 | 1.52 |
| 12:05 ET | 400 | 1.51 |
| 12:07 ET | 3000 | 1.52 |
| 12:16 ET | 100 | 1.515 |
| 12:20 ET | 100 | 1.5299 |
| 12:27 ET | 100 | 1.51 |
| 12:30 ET | 300 | 1.52 |
| 12:32 ET | 147 | 1.52 |
| 12:34 ET | 350 | 1.52 |
| 12:54 ET | 2000 | 1.54 |
| 01:03 ET | 803 | 1.53 |
| 01:21 ET | 1200 | 1.52 |
| 01:26 ET | 700 | 1.5299 |
| 01:50 ET | 100 | 1.5213 |
| 02:04 ET | 550 | 1.53 |
| 02:18 ET | 300 | 1.53 |
| 02:38 ET | 500 | 1.535 |
| 02:47 ET | 10700 | 1.535 |
| 03:03 ET | 824 | 1.53 |
| 03:18 ET | 100 | 1.53 |
| 03:20 ET | 6817 | 1.52 |
| 03:21 ET | 340 | 1.51 |
| 03:32 ET | 297 | 1.52 |
| 03:34 ET | 100 | 1.51 |
| 03:38 ET | 342 | 1.51 |
| 03:43 ET | 100 | 1.515 |
| 03:45 ET | 500 | 1.515 |
| 03:48 ET | 200 | 1.515 |
| 03:50 ET | 5079 | 1.518 |
| 03:52 ET | 4849 | 1.528 |
| 03:54 ET | 878 | 1.54 |
| 03:56 ET | 3200 | 1.538 |
| 03:59 ET | 25113 | 1.55 |
Sep 6, 2024
Sep 4, 2024
Press Release: Milestone Pharmaceuticals Appoints Industry Veteran Joseph Papa to its Board of Directors, from 8:01AM ET on Wednesday Sep 04, 2024 by Dow Jones
8:01AM ET on Wednesday Sep 04, 2024 by Dow JonesMilestone Pharmaceuticals Appoints Industry Veteran Joseph Papa to its Board of Directors, from 8:01AM ET on Wednesday Sep 04, 2024 by Dow Jones
8:01AM ET on Wednesday Sep 04, 2024 by Dow Jones
Sep 3, 2024
Milestone(R) Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference, from 8:00AM ET on Tuesday Sep 03, 2024 by Dow Jones
8:00AM ET on Tuesday Sep 03, 2024 by Dow Jones
Aug 26, 2024
Milestone(R) Pharmaceuticals to Present Data on Etripamil at the ESC Congress 2024, from 8:00AM ET on Monday Aug 26, 2024 by Dow Jones
8:00AM ET on Monday Aug 26, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Milestone Pharmaceuticals Inc | 82.6M | -1.5x | --- |
MediciNova Inc | 82.9M | -11.4x | --- |
Vistagen Therapeutics Inc | 81.2M | -2.1x | --- |
Ovid Therapeutics Inc | 83.0M | -2.8x | --- |
Genelux Corp | 81.8M | -2.3x | --- |
Regencell Bioscience Holdings Ltd | 82.4M | -17.4x | --- |
Company Information
Milestone Pharmaceuticals Inc. is a Canada-based biopharmaceutical company. The Company is focused on the development and commercialization of cardiovascular medicines. Its lead product candidate, etripamil, is a potent rapid-onset calcium channel blocker that the Company designed and is developing as a rapid-onset nasal spray to be administered by patients. The Company is also focused on developing etripamil to treat paroxysmal supraventricular tachycardia (PSVT) with a subsequent indication to treat atrial fibrillation with rapid ventricular rate (AFib-RVR) and other cardiovascular indications.
Contact Information
- Headquarters
- 420-1111 boul. Dr.-Frederik-PhilipsMONTREAL, QC, Canada H4M 2X6
- Phone
- 514-336-0444
- Fax
- 514-336-0444
Executives
- Non-Executive Independent Chairman of the Board
- Robert Wills
- President, Chief Executive Officer
- Joseph Oliveto
- Chief Financial Officer, Executive Vice President of Corporate Development
- Amit Hasija
- Chief Operating Officer
- Jeffrey Nelson
- Chief Medical Officer
- David Bharucha
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $82.6M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 53.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.72 |
EPS | $-1.01 |
Book Value | $0.50 |
P/E Ratio | -1.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
